• Alnylam Pharmaceuticals, Inc.: JP Morgan upgrades to overweight from neutral with a target price raised from USD 280 to USD 328.
  • Choice Hotels International, Inc.: Redburn Atlantic upgrades to neutral from sell with a target price raised from USD 128 to USD 132.
  • Coherent Corp.: Raymond James downgrades to strong buy from outperform with a price target reduced from USD 110 to USD 91.
  • General Mills, Inc.: Baptista Research downgrades to hold from outperform with a price target reduced from USD 73.30 to USD 64.90.
  • Lumentum Holdings Inc.: Raymond James downgrades to strong buy from outperform with a target price reduced from USD 96 to USD 82.
  • Nov Inc.: RBC Capital upgrades to outperform from sector perform with a target price of USD 22.
  • Ulta Beauty, Inc.: Baptista Research upgrades to buy from hold with a price target reduced from USD 471 to USD 470.30.
  • Williams-Sonoma, Inc.: Baptista Research upgrades to hold from underperform with a price target raised from USD 168.30 to USD 176.70.
  • Wyndham Hotels & Resorts, Inc.: Redburn Atlantic upgrades to buy from neutral with a target price raised from USD 110 to USD 115.
  • Ecolab Inc.: Redburn Atlantic downgrades to neutral from buy with a price target raised from USD 200 to USD 270.
  • Micron Technology, Inc.: CTBC Securities Investment Service Co LTD maintains its add recommendation with a price target reduced from 165 to USD 114.
  • Rh: Citigroup maintains its buy recommendation and reduces the target price from USD 556 to USD 437.